Clinical aspects of chronic granulomatous disease

Current Opinion in Hematology

Volumn 8, Issue 1, 2001, Pages 17-22

  Johnston Jr , Richard B ^a  

^a University of Colorado School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; GAMMA INTERFERON; ITRACONAZOLE; RAC PROTEIN; RAC2 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ASPERGILLUS NIDULANS; BACTERIAL VIRULENCE; BONE MARROW TRANSPLANTATION; BURKHOLDERIA CEPACIA; CHORIORETINITIS; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE THERAPY; HISTOCOMPATIBILITY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOUSE; MYCOSIS; NONHUMAN; PHAGOCYTE; PNEUMONIA; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RESPIRATORY BURST; REVIEW; SEPSIS; STAPHYLOCOCCUS; X CHROMOSOME LINKAGE;

GRANULOMATOUS DISEASE, CHRONIC; HUMANS;

EID: 0035163428     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200101000-00004     Document Type: Review

References (46)

1. 2 sensor in airway chemoreceptors: Evidence from K+ current modulation in wild-type and oxidase-deficient mice
2. 2-forming NADPH oxidase in microglia, monocytes, and neutrophils: A possible inflammatory mechanism of neuronal damage in Alzheimer's disease
3. Chronic granulomatous disease: Report on a national registry of 368 patients
4. Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients
5. Chronic granulomatous disease in Japan: Incidence and natural history
6. NADPH oxidase: An update
7. The NADPH-dependent oxidase of phagocytes
8. Activation of the neutrophil respiratory burst oxidase
9. Genetic, biochemical, and clinical features of chornic granulomatous disease
10. X-linked chronic granulomatous disease: Mutations in the CYBB gene encoding the gp91-phox component of the repiratory-burst oxidase
11. Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22phox
12. Molecular characterization of autosomal recessive chronic granulomamtous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox
13. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease
14. Diagnostic criteria for primary immunodeficiencies
15. Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease
16. Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase (G6PD) with defective bactericidal activity
17. Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic hemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase
18. Chronic granulomatous disease in adults
19. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease
20. Chronic granulomatous disease
21. Aspergillus nidulans infection in chronic granulomatous disease
22. Invasive pulmonary aspergillosis in a critically ill neonate: Case report and review of invasive aspergillosis during the first 3 months of life
23. Sensitization to Aspergillus species in the congenital neutrophif disorders chronic granulomatous disease and hyper-E syndrome
24. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease
25. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease
26. Infection with Pseudomonas cepacia in chronic granulomatous disease: Role of nonoxidative killing by neutrophifs in host defense
27. Virulence of catalase-deficient Aspergillus nidulans in p47phoxmice: Implications for fungal pathogenicity and host defense in chronic granulomatous disease
28. Chorioretinal lesions in patients and carriers of chronic granulomatous disease
29. Current concepts: Monocytes and macrophages
30. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
31. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation
32. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency
33. Follow up of patients with chronic granulomatous disease diagnosed since 1990
34. Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease
35. Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils
36. Dose-dependent enhancements by interferon-γ on functional responses of neutrophils from chronic granutomatous disease patients
37. Increased phagocyte FcγR1 expression and improved Fcγ-receptor-mediated phagocytosis after in vivo recombinant human interferon-γ treatment of normal human subjects
38. IFN - Mediated control of Coxiella burnetii survival in monocytes: The role of cell apoptosis and TNF
39. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation
40. Bone marrow transplantation for chronic granulomatous disease: Long-term follow-up and review of literature
41. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplanatation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B
42. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease
43. Gene therapy for chronic granulomatous disease
44. Progress in gene therapy for chronic granulomatous disease
45. Extended production of oxidase normal neutrophils in X-linked chronic granulomatous disease (CGD) following gene therapy with gp91 phox transduced CD34+ cells